Walleye Trading
DRNA

Walleye Trading’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Walleye Trading’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,900
Closed -$6 – 5129
2017
Q1 		$6 Buy
+1,900
New +$5.35K ﹤0.01% 4432
2016
Q4 		– Sell
-2,100
Closed -$12K – 5354
2016
Q3 		$12K Buy
+2,100
New +$7.36K ﹤0.01% 4368

Other funds holding DRNA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Walleye Trading's DRNA Position: Q2 2017 in Review

Walleye Trading sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2017, closing a stake of 1,900 shares — an estimated $6 sold.

Walleye Trading first reported a position in DRNA in Q3 2016 and held it in 2 quarters. The position peaked at $12K in Q3 2016. 36 funds tracked by Wall St. Rank hold DRNA as of Q2 2017.

  • Walleye Trading reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Walleye Trading sold 1,900 Dicerna Pharmaceuticals, Inc. shares in Q2 2017, an estimated $6.
  • Walleye Trading first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • Walleye Trading's Dicerna Pharmaceuticals, Inc. position peaked at $12K in Q3 2016.
  • 36 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2017.

Based on Walleye Trading's 13F filing for Q2 2017, filed 14 Aug 2017.